O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.86B
AUM Growth
+$1.15B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
137
New
Increased
Reduced
Closed

Top Buys

1
+$186M
2
+$115M
3
+$60.8M
4
ABBV icon
AbbVie
ABBV
+$53.1M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$45.4M

Top Sells

1
+$83.2M
2
+$60M
3
+$58.4M
4
UNH icon
UnitedHealth
UNH
+$56.5M
5
CELG
Celgene Corp
CELG
+$53.8M

Sector Composition

1 Healthcare 86.06%
2 Technology 0.09%
3 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$572M 7.04%
1,734,934
2
$377M 4.63%
5,314,800
+322,200
3
$324M 3.99%
1,060,700
-34,400
4
$310M 3.81%
5,966,400
+501,400
5
$296M 3.64%
9,941,551
+2
6
$286M 3.51%
2,315,900
-199,400
7
$282M 3.46%
2,270,000
+1,494,800
8
$246M 3.03%
4,793,800
+1,032,900
9
$221M 2.72%
4,215,000
+457,000
10
$202M 2.49%
1,398,594
-242,916
11
$199M 2.45%
5,952,000
-1,745,000
12
$191M 2.35%
2,742,800
-771,400
13
$191M 2.35%
3,905,500
-309,000
14
$175M 2.16%
5,448,200
-798,800
15
$170M 2.09%
4,253,555
+34,950
16
$168M 2.06%
1,393,200
-141,000
17
$167M 2.06%
3,124,000
-945,000
18
$163M 2.01%
1,056,800
+283,800
19
$162M 1.99%
539,000
-199,800
20
$157M 1.94%
2,097,000
+810,000
21
$147M 1.81%
3,026,700
+2,356,200
22
$145M 1.78%
2,669,256
23
$141M 1.74%
5,345,600
+1,108,000
24
$118M 1.45%
3,858,694
+113,832
25
$102M 1.26%
579,000
+224,000
1
2 3 4 5